DTP Branches and Offices
Drug Synthesis and Chemistry Branch (DSCB)
The Drug Synthesis and Chemistry Branch is responsible for the following activities in support of the discovery and development of novel anti-cancer agents:
- Worldwide scientific liaison activities with universities and industries to stimulate the submission of a wide variety of synthetic compounds, and pure natural products for in vitro anti-cancer screening
- Management of the acquisition, synthesis, storage, inventory, documentation, and distribution of chemical samples for research purposes to NIH and external investigators
- Acquisition of pre-clinical and clinical anti-cancer small-molecule chemotherapeutics for evaluation in the NCI-60 cell-line screen
- Synthetic and medicinal chemistry resource and expertise in support of NExT development and discovery projects.
Organization
| Name | Position | |
|---|---|---|
| Joel Morris, Ph.D. | Branch Chief | joel.morris@nih.gov |
| Stephen L. White, Ph.D. | Chemist | whitesl@mail.nih.gov |
| Donn G. Wishka | Chemist | donn.wishka@nih.gov |
| Mark Kunkel, Ph.D. | Biologist | kunkelm@mail.nih.gov |
| Bill Moore, Ph.D. | Head, Laboratory of Synthetic Chemistry, Leidos |
moorewj@mail.nih.gov |
Mailing Address:
Dr. Joel Morris, Branch Chief
National Cancer Institute
DTP/DSCB
9609 Medical Center Drive
Rm 4W128/MSC 9734
Bethesda, MD 20892
Express Mail and Courier Address:
Dr. Joel Morris, Branch Chief
National Cancer Institute
DTP/DSCB
9609 Medical Center Drive
Rm 4W128/MSC 9734
Bethesda, MD 208502
Email: ncidtpinfo@mail.nih.gov
About the Branch Chief
Joel Morris serves as Chief of the Drug Synthesis & Chemistry Branch (DSCB), Developmental Therapeutics Program at the National Cancer Institute. Prior to his current appointment in 2010, Dr. Morris spent a significant tenure in the pharmaceutical industry as a Senior Scientist with The Upjohn Company/Pharmacia & Upjohn, and as a Research Fellow with Pfizer. More…